How Do We Know That Chemotherapy for AML Is Working?

At the 58th American Society of Hematology (ASH) Annual Meeting & Exposition, Dr Susan O'Brien, Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer, explains that an aim of chemotherapy for patients with acute myeloid leukemia (AML). Watch now to learn more.

This programme has been supported by Pfizer, through an unrestricted educational grant to the Patient Empowerment Foundation

This article was originally published March 15, 2016 and most recently updated October 14, 2019.
© 2024 HealthCentral LLC. All rights reserved.

More on Acute Myeloid Leukemia